POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 1 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,864 | +96.2% | 783,071 | +45.0% | 0.00% | +200.0% |
| Q2 2023 | $950 | -48.9% | 540,024 | -10.5% | 0.00% | -50.0% |
| Q1 2023 | $1,858 | +78.7% | 603,200 | +207.3% | 0.00% | +100.0% |
| Q4 2022 | $1,040 | -99.9% | 196,300 | -42.8% | 0.00% | -50.0% |
| Q3 2022 | $1,212,000 | +23.5% | 343,300 | -9.7% | 0.00% | +100.0% |
| Q2 2022 | $981,000 | +17.1% | 380,100 | +103.3% | 0.00% | 0.0% |
| Q1 2022 | $838,000 | +265.9% | 187,000 | +456.5% | 0.00% | – |
| Q4 2021 | $229,000 | +143.6% | 33,600 | +160.5% | 0.00% | – |
| Q3 2021 | $94,000 | – | 12,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $7,605,000 | 1.52% |
| Privium Fund Management (UK) Ltd | 48,470 | $353,000 | 0.38% |
| Pentwater Capital Management LP | 4,967,227 | $36,211,000 | 0.37% |
| J. Goldman & Co LP | 301,391 | $2,197,000 | 0.11% |
| Perceptive Advisors | 787,745 | $5,743,000 | 0.08% |
| KNOTT DAVID M | 29,566 | $216,000 | 0.08% |
| Virtus ETF Advisers LLC | 23,082 | $168,000 | 0.07% |
| Altium Capital Management LP | 32,238 | $235,000 | 0.06% |
| Advisory Services Network, LLC | 268,290 | $1,956,000 | 0.06% |
| MCF Advisors LLC | 66,185 | $482,000 | 0.05% |